AI agents in Alzheimer’s disease management: challenges and future directions
Gerasimos Grammenos, Aristidis G. Vrahatis, Konstantinos Lazaros, Themis P. Exarchos, Panagiotis Vlamos, Marios G. Krokidis · 2026
Read AI agents in Alzheimer’s disease management: challenges and future directions by Gerasimos Grammenos, Aristidis G. Vrahatis, Konstantinos Lazaros, Themis P. Exarchos, Panagiotis Vlamos, Marios G. Krokidis (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12812870.txt.
Description
Gerasimos Grammenos and five co-authors give a view on AI agents in care for Alzheimer's disease, with open bars and next steps. Most AI tools in this field still do one narrow job, use one kind of data, and lack clear grounds for their calls. Agent-style AI could read scans, gene data, thought tests, and acts over time as one case.
Such agents could track how the ill state shifts, point to drug aims, and back care choices. In time, an agent might note gaps in its own facts and ask for the right new data. The authors stress rules, clear logic, and close work with doctors. Patient-first care stays the test for safe use.
Catalog record
| CREATOR | Gerasimos Grammenos, Aristidis G. Vrahatis, Konstantinos Lazaros, Themis P. Exarchos, Panagiotis Vlamos, Marios G. Krokidis |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |